← FDA Drug Approvals (Drugs@FDA)

CABERGOLINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ACTAVIS LABS FL INC · Approved 2008-04-21

Drug application

FDA Application #

ANDA078035

Application type

Abbreviated New Drug Application (Generic)

Brand name

CABERGOLINE

Generic name

Cabergoline

Active ingredients

CABERGOLINE

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

ACTAVIS LABS FL INC

First approval

2008-04-21

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown